Foghorn Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | +206.7% | +1,357.8% | +77.6% | -33.8% | +36.8% | |
| – | +373.1% | +3,118.9% | -87.0% | -99.7% | +570,364.9% | -97.2% | +6.8% | |
| – | – | – | – | +1,356.3% | +77.8% | -33.8% | +22.0% | |
| – | +109.0% | +30.1% | +39.2% | +31.5% | +3.9% | -13.8% | -9.6% | |
| – | +39.3% | +67.3% | +93.2% | +41.5% | +5.3% | -12.4% | -2.9% | |
| – | +89.2% | -77.2% | +807.5% | +33.6% | +4.2% | -11.8% | -12.5% | |
| – | – | – | – | – | – | – | – | |
| – | +45.6% | +81.3% | +94.7% | +506.9% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +550.6% | +81.3% | +94.7% | -100.4% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.